[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.168.87. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
From the Centers for Disease Control and Prevention
June 10, 2009

Notice to Readers: National Vaccine Advisory Committee Recommendations on Vaccine Financing

JAMA. 2009;301(22):2322. doi:

MMWR. 2009;58:403

In September 2008, the National Vaccine Advisory Committee (NVAC), a federal advisory group, approved a series of recommendations to improve vaccine financing systems in the United States. These 24 recommendations, the final product of 2 years of work, were developed with broad input and consensus from stakeholders, including health-care providers, consumers, insurers, vaccine manufacturers, state and local public health authorities, and state and local government and Medicaid agencies.

The committee recommendations are available at http://www.hhs.gov/nvpo/nvac/reports.html. A report discussing the issues surrounding vaccine financing and the development of the recommendations is available at http://www.hhs.gov/nvpo/nvac/nvacvfwgreport.pdf.

×